106429-08-7

Basic information

• Product Name: 6-Benzothiazolecarboxaldehyde,2-amino-(9CI)
• Synonyms: 6-Benzothiazolecarboxaldehyde,2-amino-(9CI);2-AMinobenzothiazole-6-carboxaldehyde;2-AMino-benzothiazole-6-carbaldehyde
• CAS NO: 106429-08-7
• Molecular Formula: C₈H₆N₂OS
• Molecular Weight: 178.21104
• Product Categories: BENZOTHIAZOLE
• Mol File: 106429-08-7.mol

Chemical Properties

• Melting Point: >300 °C
• Boiling Point: 388.9±34.0 °C(Predicted)
• Appearance: /
• Density: 1.482±0.06 g/cm3(Predicted)
• PKA: 2.77±0.10(Predicted)
• CAS DataBase Reference: 6-Benzothiazolecarboxaldehyde,2-amino-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Benzothiazolecarboxaldehyde,2-amino-(9CI)(106429-08-7)
• EPA Substance Registry System: 6-Benzothiazolecarboxaldehyde,2-amino-(9CI)(106429-08-7)

Safety Data

• Hazardous Substances Data: 106429-08-7(Hazardous Substances Data)

Upstream product

• 2591-86-8 N-Formylpiperidine 
• 2516-40-7 2-bromo-1,3-benzothiazole 
• 50850-93-6 ethyl 2-aminobenzothiazole-6-carboxylate 
• 106429-07-6 (2-aminobenzo[d]thiazol-6-yl)methanol 
• 556-18-3 4-aminobenzaldehyde 
• 15192-76-4 copper(II) thiocyanate 

Downstream Products

• 924287-02-5 C₁₆H₁₁N₃OS 

Relevant articles and documents

D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats

Significant unmet needs exist for development of better pharmacotherapeutic agents for major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) as the current drugs are inadequate. Our goal in this study is to investigate behavioral pharm

Substituted Pyran Derivatives

Certain 3,6-disubstituted and 2, 4, 5-trisubstituted pyran derivatives that exhibit potent activity on monoamine transport systems are provided. The 3, 6 and 2, 4, 5 pyrans are useful in probing the effects of their binding to monoamine transporter system

Benzothiazole based inhibitors of p38α MAP kinase

Rational design, synthesis, and SAR studies of a novel class of benzothiazole based inhibitors of p38α MAP kinase are described. The issue of metabolic instability associated with vicinal phenyl, benzo[d]thiazol-6-yl oxazoles/imidazoles was addressed by t

BENZOTHIAZOLE AND AZABENZOTHIAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS

A compound of Formula (I), or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from: (a); (b); (c); or (d), further wherein R1, R2, R3, R4, R5, R6, R7, and W are as described herein. Also discl

Novel β-lactam antibiotics

Antibacterially active and animal growth-promoting novel β-lactam compounds of the formula STR1 in which R1 represents the radical STR2 Y representing N or CR9, or Y--R7 representing >C=O or >C=N--R7, Z representing O, S, or NR10, and R2 represents hydrogen or a protective group.